相关实验视频
Updated: Jun 25, 2025

08:49
Models of Bone Metastasis
Published on: September 4, 2012
42.1K
交叉路径:解开癌症到骨转移的复杂旅程
Nour Arakil1, Shahid Akhtar Akhund1, Basant Elaasser1
1Department of Anatomy, College of Medicine, Alfaisal University, Riyadh 1153, Saudi Arabia.
Biomedicines
|May 25, 2024
概括
骨转移,在晚期癌症中很常见,破坏骨重塑. 了解癌细胞和骨微环境的相互作用是新疗法和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 骨生物学 骨生物学 骨生物学
- 癌症转移 癌症转移
背景情况:
- 骨转移是晚期乳腺癌,前列腺癌和肺癌的一个重大挑战.
- 癌细胞向骨扩散会破坏骨质细胞-骨质细胞平衡,导致骨并发症并影响患者的生活质量.
研究的目的:
- 审查癌细胞与骨微环境在骨转移的发展中的复杂相互作用.
- 检查推动骨转移进展的遗传,分子和细胞机制.
- 批评当前的诊断方法,并讨论治疗干预的含义.
主要方法:
- 文献综述专注于癌症细胞与骨相互作用.
- 分析骨结构,重塑动力学和分子通路 (细胞因子,生长因子).
- 对诊断成像技术的批评和对治疗策略的评估.
主要成果:
- 骨头是癌症进展的积极参与者,而不仅仅是被动站点.
- 癌细胞通过特定的遗传和分子途径利用骨重塑过程.
- 当前的诊断和治疗正在随着对骨转移生物学的更深入理解而发展.
结论:
- 对骨转移生物学有细微的理解对于开发向治疗和管理骨相关事件至关重要.
- 综合瘤学,放射学,分子生物学和遗传学的多学科方法对于改善患者的预后和生活质量至关重要.
- 持续的研究对于确定新的治疗点和完善骨转移的管理策略至关重要.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

